Home › Funds › REAP Financial Group, LLC › DOCT

REAP Financial Group, LLC position in DOCT

FIRST TR EXCHNG TRADED FD VI

REAP Financial Group, LLC reported holding 203,712 shares of DOCT (FIRST TR EXCHNG TRADED FD VI) in its Q3 2026 13F filing — a position valued at US$9.8M, representing 1.60% of its reported portfolio and ranking #17 among its reported holdings. REAP Financial Group, LLC has disclosed DOCT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)203.71K sh
Reported value held$9.79M
Portfolio Weight1.60%
First reportedQ4 2023
Last changeReduce
Updated2026-11-03

Last updated: 2026-11-03 · Source: SEC EDGAR Form 13F-HR

How REAP Financial Group, LLC's DOCT position evolved

REAP Financial Group, LLC first disclosed a stake in DOCT in Q4 2023 at 237,329 shares (US$8.6M). The position peaked in Q4 2024 at 557,144 shares, worth US$21.9M. Across 12 filings, REAP Financial Group, LLC increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 203,712 shares valued at US$9.8M — a reduction of -11,566 shares quarter over quarter.. Notable position changes include a 155% increase in Q4 2024 (shares fell 3% over the following quarter), a 34% trim in Q2 2025 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 237.33K $8.63M New
Q1 2024 235.00K $8.84M Reduce
Q2 2024 230.96K $8.87M Reduce
Q3 2024 218.84K $8.54M Reduce
Q4 2024 557.14K $21.93M Add
Q1 2025 487.07K $18.68M Reduce
Q2 2025 320.48K $13.16M Reduce
Q3 2025 301.58K $13.03M Reduce
Q4 2025 262.83K $11.64M Reduce
Q1 2026 220.50K $9.58M Reduce
Q2 2026 215.28K $10.05M Reduce
Q3 2026 203.71K $9.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DOCT and 13F data

DOCT (FIRST TR EXCHNG TRADED FD VI) is a company whose sector is not yet classified in our data. 36 other funds we track also report a position in DOCT — the largest reported positions include OGOREK ANTHONY JOSEPH /NY/ /ADV (US$13.3M), Wood Tarver Financial Group, LLC (US$8.3M), Per Stirling Capital Management, LLC. (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DOCT

All DOCT fund holders →

FAQ

How long has REAP Financial Group, LLC held DOCT?

REAP Financial Group, LLC has disclosed DOCT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is REAP Financial Group, LLC's current position in DOCT?

As of Q3 2026, REAP Financial Group, LLC holds 203.71K shares of DOCT (FIRST TR EXCHNG TRADED FD VI), valued at $9.79M, representing 1.60% of its reported portfolio and ranking #17.

Has REAP Financial Group, LLC been buying or selling DOCT?

In the latest 13F filing (Q3 2026), REAP Financial Group, LLC reduced its position in DOCT. The position peaked in Q4 2024 at 557.14K shares.

Which other funds hold DOCT?

Other major institutional holders of DOCT include OGOREK ANTHONY JOSEPH /NY/ /ADV, Wood Tarver Financial Group, LLC, Per Stirling Capital Management, LLC., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.